DESCRIPTION

In 2013, businessman and philanthropist T. Denny Sanford committed $100 million to the creation of the Sanford Stem Cell Clinical Center (Sanford Center) at UC San Diego. This gift established the Sanford Center, a $286 M program to accelerate development of drugs and cell therapies inspired by and derived from current human stem cell research. These advancements establish, promote and disseminate clinical trials and patient therapies that will help more quickly transform promise into reality.

Sanford Stem Cell Clinical Center (Sanford Center) is among the University's most highly visible and top priority interdisciplinary and multi-institutional programs. Sanford Center provides essential physical and human resources needed to leverage stem cell research currently being conducted at UC San Diego. Due to the complexity of regenerative medicine projects and substantial institutional investment, on a daily basis Sanford Center personnel works with a large variety of departments in Health Sciences, Health System, and the school of engineering.

Sanford Center integrates its clinical operations at two UC San Diego medical centers - Jacobs Medical Center (JMC) and the Koman Outpatient Pavilion (KOP) - encompassing 12 inpatient beds and outpatient exam rooms. We have contributed $12.5M towards the capital construction of JMC and KOP. Sanford Center is also a significant contributor ($3M) to the expansion and operations of UC San Diego's GMP facility – Advanced Cell Therapy Laboratory (ACTL), located at 10300 Campus Point Dr, San Diego, CA 92121. The ACTL consists of two ISO 7 clean rooms and a laboratory, occupying 1675 sqft. In addition, through its basic science arm – UCSD Stem Cell Program - Sanford Center provides needed resources and coordination to research conducted at the Sanford Consortium for Regenerative Medicine – an innovative